Conmed (CNMD) Misses Q4 EPS by 48c

Conmed (NYSE: CNMD) reported Q4 EPS of $0.42, $0.48 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $250.9 million versus the consensus estimate of $302.51 million.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• UBS: 'We Believe Dollar Tree (DLTR) is Turning From a Transformation to a Growth Story'
• INVO Fertility (IVF) Tops Q2 EPS by 105c